Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
m&a
national blog main
national top stories
2
×
2019
activism
acute hepatic porphyria
alnylam pharmaceuticals
bernie sanders
biopharma
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
buyout
celgene
charges
congress
crisis
deals
detroit blog main
detroit top stories
drug prices
duchenne
easl
europe blog main
europe top stories
fatty liver disease
givosiran
house of representatives
indiana blog main
indiana top stories
indivior
insulin
intercept pharmaceuticals
lawsuit
legal
What
approval
2
×
gene
2
×
therapy
advanced
alnylam’s
betting
bff
billion
bio
biopharma
conference
deal
deals
devoted
disease
drug
duchenne
easl
fda
form
historic
kicked
liver
major
medicine
puts
race
recently
rna
roche
roundup
sarepta
second
swiss
therapeutics
treat
updates
won
world's
Language
unset
Current search:
approval
×
" national top stories "
×
gene
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More